You are here:

Fast Facts

MSDs  undermine the productivity of European workers

• Forty-four million (one in six) members of the EU workforce have a long-standing health condition or disability which affects their ability to work

• MSDs result in more sickness absence than any other health condition, and cost European countries up to 240 billion Euros annually

People with MSDs who are able to work experience health, social, psychological and economic benefits

• People who stay in work have significantly fewer health-related problems over the course of their lives, more positive interactions in social and relationship measures, and contribute not only to their own financial well-being but to that of the communities in which they live

Early detection and effective intervention significantly improves outcomes in the management of  MSDs

• Studies in chronic conditions such as RA demonstrate dramatic improvements in health measures when action is taken to adjust treatments until optimal control is achieved

• Partnerships between workplaces and employees dramatically increase the ability of people living with MSDs to stay in work

• Investing in effective management of MSDs is cost-effective

Fit for Work brings together for the first time key stakeholders from both the work and health arenas to drive important policy changes, armed with a solid evidence base

Governments, business, the healthcare community and patients need to collaborate to deliver interventions that allow those living with MSDs to retain jobs, maintain access to employment and maximise their quality of working life